This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Assurant (AIZ) Q3 Earnings Beat, Revenues Miss Estimates
by Zacks Equity Research
Assurant's (AIZ) Q3 results reflect Global Automotive premium growth and higher net investment income, offset by higher catastrophe reinstatement premiums and expenses.
EverQuote (EVER) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
EverQuote's (EVER) Q3 results witnessed lower revenues from the Automotive and Other insurance vertical offset by lower expenses.
Assurant (AIZ) Q3 Earnings Beat Estimates
by Zacks Equity Research
Assurant (AIZ) delivered earnings and revenue surprises of 1% and 1.81%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stocks' Q3 Earnings on Nov 1: AIG, PRU and More
by Tanuka De
Better pricing, solid retention and renewals, exposure growth and accelerated digitalization are likely to aid third-quarter results of insurers like AIG, RNR, PRU, AIZ and UNM. However, an active catastrophe environment is likely to have weighed on insurers' performance.
Goosehead Insurance (GSHD) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Goosehead (GSHD) delivered earnings and revenue surprises of 33.33% and 6.80%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's What to Expect From Assurant (AIZ) in Q3 Earnings
by Zacks Equity Research
Assurant's (AIZ) in Q3 earnings is likely to benefit from improved net earned premiums, higher fees and other income and net investment income. However higher cat loss is a dampener.
Will Kemper (KMPR) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Kemper (KMPR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Assurant (AIZ) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Assurant (AIZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Should You Hold Assurant (AIZ) Stock in Your Portfolio?
by Zacks Equity Research
Higher trade-in volumes, international earnings, and income from fixed maturity securities, and a solid capital management policy continue to drive Assurant (AIZ).
Implied Volatility Surging for Assurant (AIZ) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Assurant (AIZ) stock based on the movements in the options market lately.
Assurant (AIZ) Boosts Mobile Device Protection With T-Mobile
by Zacks Equity Research
Assurant (AIZ) extends longstanding partnership with T-Mobile to enhance the mobile customer experience.
Assurant (AIZ) Expands Technology Portfolio With BuyBack Booth
by Zacks Equity Research
Assurant's (AIZ) strategic partnership with BuyBack Booth will help expand leading device trade-in technology portfolio.
American International Group (AIG) Down 2.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
American International Group (AIG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Assurant (AIZ) Up 2.9% Since Last Earnings Report?
by Zacks Equity Research
Assurant (AIZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should You Retain Assurant (AIZ) Stock in Your Portfolio?
by Zacks Equity Research
Continued mobile subscriber growth, organic growth across distribution channels and effective capital deployment continue to drive Assurant (AIZ).
Zacks Industry Outlook Highlights MetLife, American International, The Hartford Financial Services, Assurant and Radian Group
by Zacks Equity Research
MetLife, American International, The Hartford Financial Services, Assurant and Radian Group are part of Zacks Industry Outlook article.
5 Multiline Insurers to Watch as Exposure Increases, Price Rises
by Tanuka De
Better pricing, product redesigns, technological advancement along with optimistic growth outlook are expected to aid multiline insurers like MET, AIG, HIG, AIZ and RDN as the impact of the pandemic recedes.
MGIC Investment (MTG) Q2 Earnings Top, Revenues Miss Estimates
by Zacks Equity Research
MGIC Investment (MTG) Q2 results reflect higher premiums, partially offset by higher expenses
Assurant's (AIZ) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Assurant's (AIZ) Q2 results reflect higher net investment income offset by higher catastrophes and expenses.
Assurant (AIZ) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Assurant (AIZ) delivered earnings and revenue surprises of -8.10% and 2.75%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
James River Group (JRVR) Q2 Earnings Surpass Estimates
by Zacks Equity Research
James River Group (JRVR) delivered earnings and revenue surprises of 6.12% and 5.81%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Intercontinental Exchange (ICE) Gears Up to Post Q2 Earnings
by Zacks Equity Research
Intercontinental Exchange (ICE) Q2 likely to reflect solid performance at Exchanges, Fixed Income and Data Services, and Mortgage Technology segments.
Insurance Stocks' Earnings on Aug 1: AIZ, PRU & More
by Zacks Equity Research
Redesigning and repricing of products and services, solid retention, favorable renewals and reinsurance agreements are likely to aid insurers' second-quarter results. AIZ, PRU, VOYA, MKL, NMIH are set to report results on Aug 1.
Aflac (AFL) to Announce Q2 Earnings: Here's What to Expect
by Zacks Equity Research
Aflac's (AFL) second-quarter results are likely to reflect a decline in total net earned premiums.
Unum Group (UNM) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Unum Group (UNM) Q2 results are likely to reflect higher persistency, higher sales and favorable incidence.